Erythropoietin in cancer treatment: Considerations about Henke's article

Clinical and Translational Oncology

Volumn 7, Issue 8, 2005, Pages 332-335

  Biete Sola, Alberto ^a,b   Calvo Manuel, Felipe A ^a,c   Clavo Varas, Bernardino ^a,d   Fernández Pérez, Cristina ^e   Porto Vázquez, Carmen ^f   De La Torre Tomás, Alejandro ^a,g   Zapatero Laborda, Almudena ^a,h  

^a GICOR Grupo de Investigación Clínica en Oncologia Radioterápica   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL GENERAL DE GALICIA   (Spain)

^g HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^h HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Erythropoietin; Head and neck cancer; Radiotherapy

Indexed keywords

ERYTHROPOIETIN;

ANEMIA; ARTICLE; HEAD AND NECK TUMOR; HUMAN;

ANEMIA; ERYTHROPOIETIN; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 33644874742     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/BF02716548     Document Type: Conference Paper

References (14)

1. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003;362(9392):1255-60.
2. st edition. New York: John Wiley & Sons ltd; 2001. p. 441-2.
3. Becker A, Stadler P, Lavey RS, et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2000;46(2):459-66.
4. Hockel M, Schlenger K, Hockel S, Aral B, Schaffer U, Vaupel P. Tumor hypoxia in pelvic recurrences of cervical cancer. Int J Cancer. 1998;79(4):365-9.
5. Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 1996;6(1):10-21.
6. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159-63.
7. Lartigau E, Le Ridant AM, Lambin P, et al. Oxygenation of head and neck tumors. Cancer. 1993;71(7):2319-25.
8. Kelleher DK, Thews O, Vaupel P. Modulation of tumor oxygenation and radiosensitivity by erythropoietin. En: Vaupel P, Kelleher DK, editors. Tumor Hypoxia. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1999. p. 83-90.
9. Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol. 2000;57(1):13-9.
10. Clavo B, Pérez JL, López L, et al. Influence of haemoglobin concentration and peripheral muscle pO(2) on tumour oxygenation in advanced head and neck tumours. Radiother Oncol. 2003;66(1):71-4.
11. Joiner B, Hirst VK, McKeown SR, McAleer JJ, Hirst DG. The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse. Br J Cancer. 1993;68(4):720-6.
12. Thews O, Koenig R, Kelleher DK, Kutzner J, Vaupel P. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer. 1998;78(6):752-6.
13. Rosti V, Pedrazzoli P, Ponchio L, et al. Effect of recombinant human erythropoietin on hematopoietic and nonhematopoietic malignant cell growth in vitro. Haematologica. 1993;78(4):208-12.
14. Westphal G, Niederberger E, Blum C, et al. Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality. Tumori. 2002; 88(2):150-9.